(olaparib) Receives Positive Opinion from EU CHMP for First-Line Maintenance Treatment of …

… constipation (23%), vomiting (20%), back pain (19%), arthralgia (15%), rash (15%), thrombocytopenia (14%), dyspnea (13%), neutropenia (12%), …
Source: back pain